scispace - formally typeset
C

Claudio Ramirez

Researcher at University of California, Irvine

Publications -  15
Citations -  582

Claudio Ramirez is an academic researcher from University of California, Irvine. The author has contributed to research in topics: Viability assay & Haplogroup. The author has an hindex of 9, co-authored 15 publications receiving 506 citations.

Papers
More filters
Journal ArticleDOI

Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture

TL;DR: At clinical doses, neither ranibizumab nor aflibercept produced evidence of mitochondrial toxicity or cell death, however, bevacizuab and ziv-aflibercept showed mild mitochondrial toxicity at clinically relevant doses.
Journal ArticleDOI

Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration.

TL;DR: The findings demonstrate that mtDNA haplogroup variants mediate not only energy production and cell growth, but also cell signaling for major molecular pathways, including AMD, and support the hypothesis that mt DNA variants play important roles in numerous cellular functions and disease processes.
Journal ArticleDOI

Inhibition of apoptosis in human retinal pigment epithelial cells treated with benzo(e)pyrene, a toxic component of cigarette smoke.

TL;DR: Genistein, resveratrol, and memantine can reverse the apoptosis and oxidant production generated by B(e)P, a toxic element of smoking, and may be beneficial against retinal diseases associated with the loss of RPE cells.